Department of Ecology and Environmental Science, Umeå University, 90187 Umeå, Sweden.
Department of Chemistry, Umeå University, 90187 Umeå, Sweden.
Sci Total Environ. 2016 Oct 15;568:208-215. doi: 10.1016/j.scitotenv.2016.05.206. Epub 2016 Jun 10.
Pharmaceuticals derived from manufacturing and human consumption contaminate surface waters worldwide. To what extent such pharmaceutical contamination accumulates and disperses over time in different compartments of aquatic food webs is not well known. In this study we assess to what extent five pharmaceuticals (diphenhydramine, oxazepam, trimethoprim, diclofenac, and hydroxyzine) are taken up by fish (European perch) and four aquatic invertebrate taxa (damselfly larvae, mayfly larvae, waterlouse, and ramshorn snail), by tracing their bioconcentrations over several months in a semi-natural large-scale (pond) system. The results suggest both significant differences among drugs in their capacity to bioaccumulate and differences among species in uptake. While no support for in situ uptake of diclofenac and trimethoprim was found, oxazepam, diphenhydramine, and hydroxyzine were detected in all analyzed species. Here, the highest bioaccumulation factor (tissue:water ratio) was found for hydroxyzine. In the food web, the highest concentrations were found in the benthic species ramshorn snail and waterlouse, indicating that bottom-living organism at lower trophic positions are the prime receivers of the pharmaceuticals. In general, concentrations in the biota decreased over time in response to decreasing water concentrations. However, two interesting exceptions to this trend were noted. First, mayfly larvae (primarily grazers) showed peak concentrations (a fourfold increase) of oxazepam, diphenhydramine, and hydroxyzine about 30days after initial addition of pharmaceuticals. Second, perch (top-predator) showed an increase in concentrations of oxazepam throughout the study period. Our results show that drugs can remain bioavailable for aquatic organism for long time periods (weeks to months) and even re-enter the food web at a later time. As such, for an understanding of accumulation and dispersion of pharmaceuticals in aquatic food webs, detailed ecological knowledge is required.
制药工业和人类消费产生的药物污染物遍布全球地表水。然而,这些药物污染物在不同水生食物网的各个隔室中,随着时间的推移会积累和扩散到何种程度,目前还不是很清楚。在这项研究中,我们评估了在一个半自然的大型(池塘)系统中,经过数月追踪,五种药物(苯海拉明、奥沙西泮、甲氧苄啶、双氯芬酸和羟嗪)被鱼类(欧洲鲈鱼)和四种水生无脊椎动物类群(蜻蜓幼虫、蜉蝣幼虫、水蚤和福寿螺)吸收的程度。结果表明,这些药物在生物累积能力方面存在显著差异,同时不同物种对药物的吸收能力也存在差异。虽然没有发现双氯芬酸和甲氧苄啶在原位被吸收的证据,但所有分析的物种中都检测到了奥沙西泮、苯海拉明和羟嗪。在这里,羟嗪的生物积累因子(组织:水的比例)最高。在食物网中,最高的浓度出现在底栖物种福寿螺和水蚤中,这表明处于较低营养级的底层生物是药物的主要受体。一般来说,随着水中药物浓度的降低,生物体内的浓度会随着时间的推移而降低。然而,我们注意到了两种有趣的例外情况。首先,蜉蝣幼虫(主要是食草动物)在最初添加药物约 30 天后,其体内的奥沙西泮、苯海拉明和羟嗪浓度达到峰值(增加了四倍)。其次,鲈鱼(顶级掠食者)在整个研究期间奥沙西泮的浓度都在增加。我们的研究结果表明,药物可以在水生生物体内保持生物可利用性很长一段时间(数周到数月),甚至在以后的时间里重新进入食物网。因此,为了理解药物在水生食物网中的积累和扩散,需要详细的生态知识。